Status:
COMPLETED
Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg
Lead Sponsor:
AstraZeneca
Conditions:
Breast Cancer
Eligibility:
FEMALE
Brief Summary
The retrospective survey is to investigate the incidence of bone fracture in post-menopausal breast cancer patients with Arimidex 1mg, who were previously registered for the clinical experience invest...
Eligibility Criteria
Inclusion
- Post-menopausal breast cancer patients treated with Arimidex 1mg at the time of previously conducted clinical experience investigation.
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
2205 Patients enrolled
Trial Details
Trial ID
NCT00859560
Start Date
January 1 2008
End Date
December 1 2008
Last Update
March 11 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.